M&A in Health Care industry within DACH region
Within the DACH region, the number of transactions in the Health Care industry declined by 24% between 2022 and 2023. Switzerland, however, keeps developing positively and remains on a constant level when it comes to the number of transactions. In the following...
Unleash the Power of Interim Dividends: Flexibility and Dynamism in Corporate Law!
The revision of corporate law has ushered in a new era of flexibility for companies with the introduction of interim dividends. By directly distributing from the profit of the current fiscal year, companies can react more dynamically to current developments and...
Shaping Financial Services for Life Sciences Startups
Switzerland’s rise as the hub for life sciences startups is intrinsically linked to its growing ecosystem of biotech, medtech, and nanotech companies. This thriving ecosystem benefits from substantial investment in research and...
Challenging Second Half of 2023 for Swiss Start-Ups Confirms Projections
The second half of 2023 has witnessed a significant downturn in financing rounds (–34%) and funding volume (–10%) for Swiss start-ups compared to the previous year, according to the EY Startup Barometer Switzerland. This trend was anticipated in the market, and...
Have you already thought about drawing your pension?
Find out with us about the latest changes to the AHV 21 reform and how they could shape your financial future.
Hoffmann & Partner @Swiss Biotech Day
We will be at the Swiss Biotech Day 2024 in Basel on April 22-23, 2024. We are looking forward to meeting you at our booth #56.
Hoffmann & Partner advised Predictive Layer in its trade sale to TotalEnergies
Predictive Layer, the Swiss provider of forecasting solutions in the energy and commodity trading sector, was sold to TotalEnergies. Hoffmann & Partner acted as the exclusive financial advisor to the sellers. TotalEnergies will improve the performance of its...
EsoCap AG reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis (EoE)
Great news! Our long-standing client EsoCap AG has unveiled impressive clinical data - another milestone on the road to groundbreaking advances in healthcare! We have proudly accompanied EsoCap as CFO partner since its inception and are thrilled to witness these...
Stille AB (publ) acquires Fehling Instruments
We advised Stille, a listed Swedish medtech company, in the acquisition of Fehling Instruments based in Germany in a joint mandate with our AICA network partner Evli Corporate Finance. Through the acquisition, Stille significantly broadens its product offering of...
Hoffmann & Partner AG is once again one of the best tax experts in Switzerland in 2024.
We are pleased that we are once again among the top tax experts & fiduciaries in Switzerland this year! For the fourth time, the market research institute Statista conducted a survey on behalf of BILANZ among several thousand industry professionals and clients in...